Radiotherapy to All Residual Lesions After Chemoimmunotherapy

Clinical trial NCT06479473 · RECRUITING

Trial details

NCT number: NCT06479473
Sponsor: Anhui Provincial Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Extensive-stage Small Cell Lung Cancer

Start date: 2024-06-01
Primary completion: 2025-03-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.